Get
Noticed
HERE

Ask Pharma Compass

Free Demo Request

Global Pharmaceutical Intelligence

Smarter Sourcing, Faster Drug Launches, Quicker Business Leads, Killer Sales

    NEWS & ALERTS

    TOP 10 NEWS OF THE DAY

    NEWS LIBRARY

    Recent Approvals

    Compliance Alerts

    MARKET PLACE

    ENQUIRIES FOR APIs

    Post an enquiry PharmaCompass.com

    A technology driven company developing leading-edge technologies to revolutionize healthcare delivery is searching for suppliers of Imatinib Mesylate and Capecitabine APIs 1 kg each for in-house development purposes. The suppliers/manufacturers must support the products with an active USDMF and GMP certificate.

    Comments

    A medical devices company based in Edinburgh with its R&D centre in India is looking for suppliers/manufacturers of following active ingredients, specifically in liquid forms or in transdermally active forms for development of transdermal patches:
    1. Rivastigmine
    2. Methylphenidate
    3. Fentanyl
    4. Lidocaine

    Comments

    Royal Pharmaceutical Trading Co., a Vietnamese company which has been promoting nootropic products in hospital segment with support from local contract manufacturers is searching for supplier of Ginkgo biloba extract.The manufacturers/suppliers need to support the products with DMF (Drug Master File) and GMP certificate. Interested manufacturers/suppliers should contact Minh Duc Tran via Email: royalpharmagroup@yahoo.com or Tel: +84 243 5658497.

    Comments

    ENQUIRIES FOR FINISHED FORMULATIONS

    A vertically integrated pharmaceutical company heavily focused in research & development and in manufacturing drug intermediates, APIs & FDFs is searching for suppliers of Cetirizine 10 mg and 20 mg tablets for the Canadian market. The quantity required for the first year is 1.5 mn to 2 mn, which shall grow rapidly from the second year. The product must be from a USFDA/PICS/Health Canada approved facility.

    Comments (1)

    Redgreens LLP, a consulting firm facilitating sourcing activity for their clients is searching for suppliers/manufacturers of Ursodiol 300 mg and 500 mg capsules (Minimum Batch Size) for supply. Interested suppliers/manufacturers should contact Rushikesh via Email: business@redgreens.in or Tel: +919920636384.

    Comments

    A pharmaceutical company, based in Germany, capable of independently developing, registering and supplying finished dosage form (FDF) generic pharmaceuticals to marketing organizations internationally has an EU dossier for Silodosin 4 and 8 mg capsules available. The dossier will be submitted on February 1st, 2018 when the EU data exclusivity expires. Interested marketing / licensing partners should write to support@pharmacompass.com

    Comments

    FEATURED COMPANIES

    PARTIAL LIST OF PARTNER COMPANIES

    BLOG & ANALYSIS

    RADIO BLOG

    Pfizer exits China venture with Hisun; FDA mulls more steps to increase generic drug competition

    Pfizer exits China venture with Hisun; FDA mulls more steps to increase generic drug competition

    This week in Phispers, we look at the measures US FDA announced last week to increase competition in...

    Radio Compass

    PharmaCompass.com

    Teva’s rating cut to junk; Two Lupin facilities receive FDA warning letters

    Teva’s rating cut to junk; Two Lupin facilities receive FDA warning letters

    This week in Phispers, we look at the contrasting 2017 forecasts of Mylan and Teva, resulting from t...

    Radio Compass

    PharmaCompass.com

    One in six facilities fail to pay FDA’s user fees — is the US generic supply chain at risk?

    One in six facilities fail to pay FDA’s user fees — is the US generic supply chain at risk?

    The Generic Drug User Fee Act (GDUFA) came into effect on October 1, 2012. The law was designed to a...

    Pharmacompass.com

    Radio Compass

    RADIO DATA

    Country-wise List of Facilities Which Paid for FY2017, But Not for FY2018

    Country-wise List of Facilities Which Paid for FY2017, But Not for FY2018

    Generic Drug User Fee Act Facility Payment List as of Nov 3, 2017

    Generic Drug User Fee Act Facility Payment List as of Nov 3, 2017